Flusalazine

N/A

Report date: 2025/03/25 16:58:32

NME

Base Information

Drug NameFlusalazine

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionProstaglandin E synthase inhibitorsReactive oxygen species inhibitors

TargetsProstaglandin E synthaseReactive oxygen species

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaPancreatitis +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGnt Pharma

China Registration ClassN/A

Active CompaniesGnt Pharma

Inactive CompaniesN/A

Active IndicationsPulmonary Disease, Chronic ObstructiveAsthmaPancreatitis +[4]

Inactive IndicationsN/A

ATC CodeN/A